Our in vitro biological model of drug resistance made use of the well characterized and widely utilized estrogen receptor positive (ERα+) MCF7 breast cancer cell line (parental), and its paired cell line selected for Doxorubicin resistance (DOXRes), using our previously published in vitro protocol [14, 15]. This evidence concerns the gene ESR1 and breast cancer.